233 related articles for article (PubMed ID: 16236550)
21. Back to the future in Chagas disease: from animal models to patient cohort studies, progress in immunopathogenesis research.
Scharfstein J; Gomes Jde A; Correa-Oliveira R
Mem Inst Oswaldo Cruz; 2009 Jul; 104 Suppl 1():187-98. PubMed ID: 19753474
[TBL] [Abstract][Full Text] [Related]
22. Inflammation and Chagas disease some mechanisms and relevance.
Talvani A; Teixeira MM
Adv Parasitol; 2011; 76():171-94. PubMed ID: 21884892
[TBL] [Abstract][Full Text] [Related]
23. Acute Chagas' disease: immunohistochemical characteristics of T cell infiltrate and its relationship with T. cruzi parasitic antigens.
Fuenmayor C; Higuchi ML; Carrasco H; Parada H; Gutierrez P; Aiello V; Palomino S
Acta Cardiol; 2005 Feb; 60(1):33-7. PubMed ID: 15779849
[TBL] [Abstract][Full Text] [Related]
24. [Role of cytokines in resistance and pathology in Trypanosoma cruzi infection].
Laucella SA; Rottenberg ME; de Titto EH
Rev Argent Microbiol; 1996; 28(2):99-109. PubMed ID: 8768488
[TBL] [Abstract][Full Text] [Related]
25. Roles of Trypanosoma cruzi calreticulin in parasite-host interactions and in tumor growth.
Ramírez G; Valck C; Aguilar L; Kemmerling U; López-Muñoz R; Cabrera G; Morello A; Ferreira J; Maya JD; Galanti N; Ferreira A
Mol Immunol; 2012 Oct; 52(3-4):133-40. PubMed ID: 22673211
[TBL] [Abstract][Full Text] [Related]
26. Autoimmunity.
Cunha-Neto E; Teixeira PC; Nogueira LG; Kalil J
Adv Parasitol; 2011; 76():129-52. PubMed ID: 21884890
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of anti-R-13 antibodies in human Trypanosoma cruzi infection.
Aznar C; Lopez-Bergami P; Brandariz S; Mariette C; Liegeard P; Alves MD; Barreiro EL; Carrasco R; Lafon S; Kaplan D
FEMS Immunol Med Microbiol; 1995 Dec; 12(3-4):231-8. PubMed ID: 8745008
[TBL] [Abstract][Full Text] [Related]
28. [Non-virulence in mice of PF branch of Trypanosoma cruzi. Evaluation through xenodiagnosis, tissue culture and histopathology].
Menezes H
AMB Rev Assoc Med Bras; 1976 Apr; 22(4):111-4. PubMed ID: 829996
[No Abstract] [Full Text] [Related]
29. Antibody levels to Trypanosoma cruzi in infected patients with and without evidence of chronic Chagas' disease.
Gusmão RD; Rezende JM; Rassi A; Gam AA; Neva FA
Am J Trop Med Hyg; 1982 May; 31(3 Pt 1):452-8. PubMed ID: 6805346
[TBL] [Abstract][Full Text] [Related]
30. Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease).
Tanowitz HB; Machado FS; Jelicks LA; Shirani J; de Carvalho AC; Spray DC; Factor SM; Kirchhoff LV; Weiss LM
Prog Cardiovasc Dis; 2009; 51(6):524-39. PubMed ID: 19410685
[TBL] [Abstract][Full Text] [Related]
31. [Myocardial cellular damage and the activity of the mitochondrial ATP synthase in rats infected with a Colombian strain of Trypanosoma cruzi].
Rendón DA; Genes CM; Triana O
Biomedica; 2007 Jan; 27 Suppl 1():40-9. PubMed ID: 18154244
[TBL] [Abstract][Full Text] [Related]
32. Chronic infection in mice with Trypanosoma cruzi.
Bijovsky AT; Elizari MV; Muller LA; Katzin VJ; González Cappa SM
Rev Inst Med Trop Sao Paulo; 1983; 25(5):207-14. PubMed ID: 6424217
[No Abstract] [Full Text] [Related]
33. Involvement of neutrophils in Chagas disease pathology.
de Andrade MF; de Almeida VD; de Souza LMS; Paiva DCC; Andrade CM; de Medeiros Fernandes TAA
Parasite Immunol; 2018 Dec; 40(12):e12593. PubMed ID: 30276823
[TBL] [Abstract][Full Text] [Related]
34. Vaccine-Linked Chemotherapy Improves Benznidazole Efficacy for Acute Chagas Disease.
Jones K; Versteeg L; Damania A; Keegan B; Kendricks A; Pollet J; Cruz-Chan JV; Gusovsky F; Hotez PJ; Bottazzi ME
Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29311242
[TBL] [Abstract][Full Text] [Related]
35. Immunity and immune modulation in Trypanosoma cruzi infection.
Cardillo F; de Pinho RT; Antas PR; Mengel J
Pathog Dis; 2015 Dec; 73(9):ftv082. PubMed ID: 26438729
[TBL] [Abstract][Full Text] [Related]
36. Autoimmunity in Chronic Chagas Disease: A Road of Multiple Pathways to Cardiomyopathy?
De Bona E; Lidani KCF; Bavia L; Omidian Z; Gremski LH; Sandri TL; de Messias Reason IJ
Front Immunol; 2018; 9():1842. PubMed ID: 30127792
[TBL] [Abstract][Full Text] [Related]
37. Lack of Galectin-3 Prevents Cardiac Fibrosis and Effective Immune Responses in a Murine Model of Trypanosoma cruzi Infection.
Pineda MA; Cuervo H; Fresno M; Soto M; Bonay P
J Infect Dis; 2015 Oct; 212(7):1160-71. PubMed ID: 25805753
[TBL] [Abstract][Full Text] [Related]
38. Chronic indeterminate phase of Chagas' disease: mitochondrial involvement in infection with two strains.
Báez AL; Lo Presti MS; Fretes R; Díaz C; Pons P; Bazán PC; Strauss M; Rivarola HW; Paglini-Oliva P
Parasitology; 2013 Mar; 140(3):414-21. PubMed ID: 23137884
[TBL] [Abstract][Full Text] [Related]
39. Trypanosoma cruzi immunoproteome: Calpain-like CAP5.5 differentially detected throughout distinct stages of human Chagas disease cardiomyopathy.
Caminha MA; de Lorena VMB; de Oliveira Júnior W; Perales J; Carvalho PC; Lima DB; Cavalcanti MDGAM; Martins SM; Valente RH; Menna-Barreto RFS
J Proteomics; 2019 Mar; 194():179-190. PubMed ID: 30503829
[TBL] [Abstract][Full Text] [Related]
40. Chagas' disease: Trypanosoma cruzi vs. the host immune system. 36th forum in immunology.
Res Immunol; 1991 Feb; 142(2):123-81. PubMed ID: 1907751
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
